HomeCompareEKGGF vs GBDC

EKGGF vs GBDC: Dividend Comparison 2026

EKGGF yields 43478.26% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EKGGF wins by $1.1890295911865906e+23M in total portfolio value
10 years
EKGGF
EKGGF
● Live price
43478.26%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.1890295911865906e+23M
Annual income
$118,367,411,904,190,840,000,000,000,000.00
Full EKGGF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — EKGGF vs GBDC

📍 EKGGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEKGGFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EKGGF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EKGGF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EKGGF
Annual income on $10K today (after 15% tax)
$3,695,652.17/yr
After 10yr DRIP, annual income (after tax)
$100,612,300,118,562,220,000,000,000,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, EKGGF beats the other by $100,612,300,118,562,220,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EKGGF + GBDC for your $10,000?

EKGGF: 50%GBDC: 50%
100% GBDC50/50100% EKGGF
Portfolio after 10yr
$5.945147955932953e+22M
Annual income
$59,183,705,952,095,420,000,000,000,000.00/yr
Blended yield
99.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

EKGGF
No analyst data
Altman Z
-198.7
Piotroski
1/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EKGGF buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEKGGFGBDC
Forward yield43478.26%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$1.1890295911865906e+23M$20.78M
Annual income after 10y$118,367,411,904,190,840,000,000,000,000.00$16,389,263.41
Total dividends collected$1.1886778493816057e+23M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: EKGGF vs GBDC ($10,000, DRIP)

YearEKGGF PortfolioEKGGF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$4,358,526$4,347,826.09$12,490$1,790.28+$4.35MEKGGF
2$1,775,702,260$1,771,038,637.53$16,522$3,157.73+$1775.69MEKGGF
3$676,233,533,658$674,333,532,239.80$23,578$5,898.68+$676233.51MEKGGF
4$240,727,047,188,757$240,003,477,307,741.90$37,115$11,886.75+$240727047.15MEKGGF
5$80,105,191,727,727,180$79,847,613,787,235,220.00$66,136$26,423.57+$80105191727.66MEKGGF
6$24,917,840,645,043,868,000$24,832,128,089,895,195,000.00$137,257$66,491.44+$24917840645043.73MEKGGF
7$7,245,709,632,152,810,000,000$7,219,047,542,662,613,000,000.00$341,734$194,868.54+$7245709632152810.00MEKGGF
8$1,969,606,736,781,993,500,000,000$1,961,853,827,475,589,700,000,000.00$1,050,788$685,133.02+$1969606736781993472.00MEKGGF
9$500,511,415,390,858,850,000,000,000$498,403,936,182,502,200,000,000,000.00$4,099,314$2,974,971.01+$500511415390858838016.00MEKGGF
10$118,902,959,118,659,060,000,000,000,000$118,367,411,904,190,840,000,000,000,000.00$20,775,530$16,389,263.41+$1.1890295911865906e+23MEKGGF

EKGGF vs GBDC: Complete Analysis 2026

EKGGFStock

CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company's technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. Its proprietary device connectivity and ECG management technologies are used in medical, consumer, clinical research, and telemedicine solutions. The company's software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a web enabled ECG device that is EMR compatible; and GEMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, which are handheld ECG monitors; and Sirona telephonic and wireless event recorders, as well as HeartCheck CardiBeat. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring. Additionally, the company provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.

Full EKGGF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this EKGGF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EKGGF vs SCHDEKGGF vs JEPIEKGGF vs OEKGGF vs KOEKGGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.